Elvira Umyarova
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Donor Immune Cells (TGFbi NK Cells) and Isatuximab for the Treatment of Relapsed or Refractory Multiple Myeloma (NCT06203912) | Elvira Umyarova | 2024-03-05 |
Track Elvira Umyarova automatically
Every clearance here is in the API, with alerts when new ones post.